Augustine Therapeutics announces first patient dosed in Phase I clinical trial evaluating lead candidate AGT-100216 for the treatment of Charcot-Marie-Tooth […]
Continue Reading
Promising Results from Govorestat Trial for CMT-SORD Shared at PNS 2025 Applied Therapeutics has presented full 12-month clinical results from […]
Continue Reading
The CMTUK 2025 Conference Timetable is Here! Check what’s on and get ready for a day full of learning and […]
Continue Reading
We can confirm that Karin Rodgers has stepped down from her role as a Trustee of CMTUK, and from all […]
Continue Reading
CMTUK AGM & Conference 2025The Annual General Meeting and Conference 2025 will be held on 10th May in Stratford-upon-Avon. We […]
Continue Reading
We are deeply saddened by the passing of Daniel Tanesse, a dedicated advocate for the CMT community, a key figure […]
Continue Reading
Department for Science, Innovation and Technology Neurological conditions must be a research priority
Continue Reading
Hello! We’re excited to invite you to the next CMTUK London Support Group Face-to-Face Meet Up! It’s going to be […]
Continue Reading
We’re excited to invite you to our next CMTUK Hampshire & Sussex Support Group Meeting! This is a fantastic opportunity […]
Continue Reading
Rare disease community: open letter – gov.scot
Continue ReadingLast Updated: Wednesday 11th June, 2025